BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 38428412)

  • 1. Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells.
    Colucci M; Zumerle S; Bressan S; Gianfanti F; Troiani M; Valdata A; D'Ambrosio M; Pasquini E; Varesi A; Cogo F; Mosole S; Dongilli C; Desbats MA; Contu L; Revankdar A; Chen J; Kalathur M; Perciato ML; Basilotta R; Endre L; Schauer S; Othman A; Guccini I; Saponaro M; Maraccani L; Bancaro N; Lai P; Liu L; Pernigoni N; Mele F; Merler S; Trotman LC; Guarda G; Calì B; Montopoli M; Alimonti A
    Cancer Cell; 2024 Apr; 42(4):646-661.e9. PubMed ID: 38428412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unleashing a safe and potent pro-senescence anti-tumor strategy.
    Chen S; Sun B; Dong Z
    Cancer Cell; 2024 Apr; 42(4):504-507. PubMed ID: 38428411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells.
    Chaturvedi P; George V; Shrestha N; Wang M; Dee MJ; Zhu X; Liu B; Egan J; D'Eramo F; Spanoudis C; Gallo V; Echeverri C; You L; Kong L; Fang B; Jeng EK; Rhode PR; Wong HC
    Mol Ther; 2022 Mar; 30(3):1171-1187. PubMed ID: 35051615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner.
    Etxebeste-Mitxeltorena M; Del Rincón-Loza I; Martín-Antonio B
    Front Immunol; 2021; 12():717850. PubMed ID: 34447383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis.
    Guccini I; Revandkar A; D'Ambrosio M; Colucci M; Pasquini E; Mosole S; Troiani M; Brina D; Sheibani-Tezerji R; Elia AR; Rinaldi A; Pernigoni N; Rüschoff JH; Dettwiler S; De Marzo AM; Antonarakis ES; Borrelli C; Moor AE; Garcia-Escudero R; Alajati A; Attanasio G; Losa M; Moch H; Wild P; Egger G; Alimonti A
    Cancer Cell; 2021 Jan; 39(1):68-82.e9. PubMed ID: 33186519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells.
    Alessio N; Aprile D; Squillaro T; Di Bernardo G; Finicelli M; Melone MA; Peluso G; Galderisi U
    Aging (Albany NY); 2019 Aug; 11(15):5817-5828. PubMed ID: 31412320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy.
    Carpenter V; Saleh T; Min Lee S; Murray G; Reed J; Souers A; Faber AC; Harada H; Gewirtz DA
    Biochem Pharmacol; 2021 Nov; 193():114765. PubMed ID: 34536356
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Zhang JW; Zhang D; Yin HS; Zhang H; Hong KQ; Yuan JP; Yu BP
    Gut Microbes; 2023; 15(1):2197836. PubMed ID: 37017266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senescence-associated secretory proteins induced in lung adenocarcinoma by extended treatment with dexamethasone enhance migration and activation of lymphocytes.
    Parajuli P; Rosati R; Mamdani H; Wright RE; Hussain Z; Naeem A; Dzinic S; Polin L; Gavande NS; Ratnam M
    Cancer Immunol Immunother; 2023 May; 72(5):1273-1284. PubMed ID: 36434273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling.
    Rajagopalan S; Long EO
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20596-601. PubMed ID: 23184984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity.
    Toso A; Revandkar A; Di Mitri D; Guccini I; Proietti M; Sarti M; Pinton S; Zhang J; Kalathur M; Civenni G; Jarrossay D; Montani E; Marini C; Garcia-Escudero R; Scanziani E; Grassi F; Pandolfi PP; Catapano CV; Alimonti A
    Cell Rep; 2014 Oct; 9(1):75-89. PubMed ID: 25263564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging.
    Muñoz DP; Yannone SM; Daemen A; Sun Y; Vakar-Lopez F; Kawahara M; Freund AM; Rodier F; Wu JD; Desprez PY; Raulet DH; Nelson PS; van 't Veer LJ; Campisi J; Coppé JP
    JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity.
    Chien Y; Scuoppo C; Wang X; Fang X; Balgley B; Bolden JE; Premsrirut P; Luo W; Chicas A; Lee CS; Kogan SC; Lowe SW
    Genes Dev; 2011 Oct; 25(20):2125-36. PubMed ID: 21979375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senescent cells: Living or dying is a matter of NK cells.
    Antonangeli F; Zingoni A; Soriani A; Santoni A
    J Leukoc Biol; 2019 Jun; 105(6):1275-1283. PubMed ID: 30811627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3.
    Tripathi U; Nchioua R; Prata LGPL; Zhu Y; Gerdes EOW; Giorgadze N; Pirtskhalava T; Parker E; Xue A; Espindola-Netto JM; Stenger S; Robbins PD; Niedernhofer LJ; Dickinson SL; Allison DB; Kirchhoff F; Sparrer KMJ; Tchkonia T; Kirkland JL
    Aging (Albany NY); 2021 Sep; 13(18):21838-21854. PubMed ID: 34531331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular senescence and the tumour microenvironment.
    Takasugi M; Yoshida Y; Ohtani N
    Mol Oncol; 2022 Sep; 16(18):3333-3351. PubMed ID: 35674109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence.
    Nagesh PKB; Chowdhury P; Hatami E; Kumari S; Kashyap VK; Tripathi MK; Wagh S; Meibohm B; Chauhan SC; Jaggi M; Yallapu MM
    ACS Appl Mater Interfaces; 2019 Oct; 11(42):38537-38554. PubMed ID: 31553876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
    Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
    Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent state.
    Matsuda S; Revandkar A; Dubash TD; Ravi A; Wittner BS; Lin M; Morris R; Burr R; Guo H; Seeger K; Szabolcs A; Che D; Nieman L; Getz GA; Ting DT; Lawrence MS; Gainor J; Haber DA; Maheswaran S
    Cell Rep; 2023 Mar; 42(3):112129. PubMed ID: 36821441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
    Chambers CR; Ritchie S; Pereira BA; Timpson P
    Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.